- Earth
Science Tech is a Florida-based company with a vision of enhancing the
quality of people’s lives through varied wellness initiatives as part of a
growing $4.2 trillion industry
- The
company’s two subsidiaries have a targeted focus on helping women who
might not normally pursue health care to assess and treat STIs, as well as
on utilizing hemp derivatives as therapy for a variety of maladies
- ETST
also supports a favored entity’s efforts to gain non-profit status for
accepting grants that would further CBD studies and assist the company in
donating its products on the basis of need
The health and wellness industry continues to accelerate
annual sales of products and philosophies designed to help people live life and
love it, propelled in large part by concerns about the rising costs of health
care and the decrease in age of patients reporting select chronic ailments,
including heart disease. The Global Wellness Institute reports that wellness
industry revenues increased by 6.4 percent annually from 2015-17 to become a
$4.2 trillion market that is growing nearly twice as fast as the global
economy (http://ibn.fm/afG7j).
Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) has built a
variety of partnerships that support its two wholly owned subsidiaries, as well
as a favored non-profit entity, in their endeavors to advance consumers’
wellbeing. The company’s mission is focused on cannabis/industrial hemp and
medical devices.
Subsidiary Earth Science Pharmaceutical is committed to
bringing low-cost, non-invasive testing processes and vaccines for sexually
transmitted infections to market to help women improve the quality of their
lives. The company’s first medical device, Hygee, is a home kit designed as a
modified panty liner to allow for the self-collection of a gynecological
specimen that can be tested for two types of infections – chlamydia and
gonorrhea. It gives women the ability to self-collect specimens in a
non-clinical setting before sending them to a laboratory that will process the
specimens and notify them if they test positive so that they can seek
treatment.
The motivation behind the technology is to help women and
girls in high-risk situations, who might not be willing or able to seek out
assistance through traditional medical care facilities, take responsible action
for their own wellbeing with the help of online ordering and home screening.
ETST’s second subsidiary, Cannabis Therapeutics, is
investing in the medicinal power of hemp-derived cannabidiol (CBD). Earth
Science Tech holds three provisional application patents for a CBD product that
the company aims to use in developing treatments for breast and ovarian
cancers, and for two generic pharmaceutical drugs with a CBD foundation.
Industrial hemp-based CBD and full-spectrum oils provide the
company a core operation with increasing revenues, but Earth Science Tech has
also been invested in research and developmental lab work that it hopes to
continue for advancing varied high-quality natural hemp extracts and
identifying their distinct properties. In addition to breast and ovarian cancer
treatments, the company aims to further non-prescription therapies for chronic
pain, joint pain, inflammation, seizures, high blood pressure, memory loss,
depression, weight management, nausea and general aging-related maladies.
ETST’s formulations are expected to include options such as
capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and
whole herbs and may include products such as CBD as a natural constituent of
hemp oil, vitamins, minerals, herbs, botanicals, personal care products,
homeopathies, functional foods and other products (http://ibn.fm/5Hokn).
As a companion entity to Earth Science Tech’s subsidiary
operations, the company backs favored entity Earth Science Foundation’s effort
to become a non-profit organization that can accept grants and donations to
conduct further studies and assist in donating Earth Science Tech’s effective
CBD products to those in need.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates
relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
